Detalhe da pesquisa
1.
CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group.
Blood
; 138(13): 1137-1147, 2021 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951732
2.
CD43-positive, EWSR1::FLI1 -rearranged Soft Tissue Sarcoma in a Pediatric Patient With History of B-Cell Acute Lymphoblastic Leukemia.
J Pediatr Hematol Oncol
; 45(5): e635-e638, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37027334
3.
Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.
Proc Natl Acad Sci U S A
; 117(25): 14331-14341, 2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513686
4.
Chemotherapy roadmaps in pediatric oncology: A digital electronic medical record integrated solution.
J Oncol Pharm Pract
; 28(8): 1722-1730, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34558367
5.
IFN-γ and CD38 in AML: a T-cell engagement made in heaven?
Blood
; 143(16): 1556-1557, 2024 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635257
6.
Pediatric Hodgkin Lymphoma, Version 3.2021.
J Natl Compr Canc Netw
; 19(6): 733-754, 2021 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34214968
7.
CREBBP alterations are associated with a poor prognosis in de novo AML.
Blood
; 141(17): 2156-2159, 2023 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634304
8.
INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia.
Transplant Cell Ther
; 29(11): 674-684, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37689393
9.
Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients.
Transplant Cell Ther
; 29(6): 356.e1-356.e7, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966871
10.
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies.
Leukemia
; 37(9): 1767-1778, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452102
11.
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
Blood Adv
; 7(4): 575-585, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35482927
12.
CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group.
J Clin Oncol
; 40(3): 252-261, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34855461
13.
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL.
J Clin Oncol
; 40(9): 932-944, 2022 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767461
14.
CAR T cells for other pediatric non-B-cell hematologic malignancies.
Hematology Am Soc Hematol Educ Program
; 2020(1): 494-500, 2020 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33275678
15.
Opportunities for immunotherapy in childhood acute myeloid leukemia.
Blood Adv
; 3(22): 3750-3758, 2019 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31770440
16.
Opportunities for immunotherapy in childhood acute myeloid leukemia.
Hematology Am Soc Hematol Educ Program
; 2019(1): 218-225, 2019 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31808843
17.
Risk of T-cell Malignancy Following CAR T cells in Children, Adolescents and Young Adults.
Blood Adv
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701425
18.
Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity.
Front Oncol
; 8: 213, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29951373
19.
Integrated functional and mass spectrometry-based flow cytometric phenotyping to describe the immune microenvironment in acute myeloid leukemia.
J Immunol Methods
; 453: 44-52, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29175391
20.
Plasticity of lineage switch in B-ALL allows for successful rechallenge with CD19-directed immunotherapy.
Blood Adv
; 7(12): 2825-2830, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763522